Home > Insider Trading > Filing (0000899243-20-026476)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1743881	Bridgebio Pharma Inc.	BBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192591	J Charles Homcy	C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301	Chairman Of Pharmaceuticals	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-09-25	65,661	$36.68	1,237,363	No	4	S	Direct
Common Stock	Disposition	2020-09-25	15,396	$37.47	1,221,967	No	4	S	Direct
Common Stock	Disposition	2020-09-29	18,200	$37.50	1,203,767	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan that the Reporting Person adopted on December 13, 2019 and amended on August 26, 2020.
Represents the weighted average sale price of the shares sold from $36.26 to $37.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4.
Includes 733 shares acquired by the Reporting Person on August 14, 2020 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Represents the weighted average sale price of the shares sold from $37.26 to $37.66 per share.